Milestones
2006: Basic research and four years of “proof of concept” research. Prof. Laurens Mets and his colleagues at the University of Chicago recognize the potential of archaea for methane production and isolate a highly efficient strain.
2011: First major laboratory-scale field tests with raw biogas at a brewery digester in St. Louis, MO, USA.
2013: Pre-commercial field tests demonstrated scalability (5000L bioreactor) in Foulum, Denmark.
2014: Electrochaea GmbH established as part of Series A financing by Munich Venture Partners, btov, Sirius Venture Partners, KfW, Focus First Holdings, Energie 360°and Caliza Holding. Headquarters and laboratory space are secured in Munich, Germany. Funding received from Energinet.dk to design, build and operate the BioCat Project, a 1 MW commercial-scale field trial at a wastewater treatment plant outside Copenhagen, Denmark. Partners include Hydrogenics, Audi, HMN Gashandel, NEAS Energy and BIOFOS.
2016: The team grows/go-to-market: To establish the company’s market position, an international team of 20 engineers and scientists was formed around Mich Hein (CEO) and Doris Hafenbradl (CTO) in Munich, Germany. The world’s first 1 MW P2G plant (BioCat Project) was commissioned in Denmark, with support from Energinet. Initiated second grid scale pilot project in Switzerland with Horizon 2020 Project STORE&GO.
2017/2018: Accelerated development of high efficiency microbial electrolysis cell and laboratory pressure reactor with grant and equity funding.
2019: Storengy invests in Electrochaea. Commissioning and inauguration of the BioCat plant in Solothurn, Switzerland. Inauguration of ORBIT pilot reactor in Regensburg. First grid-injection of renewable methane produced by the BioCat system in Solothurn, Switzerland and in Avedøre, Denmark. Commissioning of BioCat plant in Golden, CO, USA.
2020: Establishment of Electrochaea Corporation, currently located in Sacramento, CA, USA.